4 Propiedates TerapéUticas De Las Algas

Usos en la industria farmacéutica y cosmética. Aplicaciones en Talasoterapia

[object Object],[object Object],[object Object],Link Artículo Completo

Campos de aplicación ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

roduct Nº E Origen Usados Alginatos y derivados (ej. Alginate sódico, Alginato de propylen glycol ) E400-405 Grandes macroalgas pardas como Laminaria hyperborea , Ascophyllum nodosum y Macrocystis species Emulsionador, suspensiones coloidales, estabilizador, agente delificante, espesante. Agar E406 Principalmente especies de Gelidium, Pterocladia, y Gracilaria Emulsionador, estabilizador, gelificantes, espesante. Carragén E407 Principalmente Eucheuma , Betaphycus , Kappaphycus , y Chondrus crispus Emulsionador, estabilizador, gelificantes, espesante.

Agar ,[object Object],[object Object],[object Object]

Las algas en la medicina china ,[object Object],[object Object],[object Object],[object Object],Curandera llevando plantas medicinales

Usos tradicionales medicina china ,[object Object],[object Object],[object Object]

Usos tradicionales medicina china ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Uso tradicional en Europa: Escocia ,[object Object],[object Object],[object Object]

Uso tradicional en Europa: Escocia ,[object Object],[object Object],[object Object],[object Object],[object Object]

Uso tradicional en Europa: El tónico victoriano y el Anti-Fat ,[object Object],[object Object],[object Object],[object Object]

Consultas de publicaiones sobre algas en el PubMed:

Principales actividades de las algas ,[object Object],[object Object],LINK Pilot clinical study to evaluate the anticoagulant activity of fucoidan Blood Coagul Fibrinolysis. 2009 Aug 18. [Epub ahead of print] Pilot clinical study to evaluate the anticoagulant activity of fucoidan Irhimeh MR , Fitton JH , Lowenthal RM . aClinical Haematology & Medical Oncology Unit, Royal Hobart Hospital, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia bDepartment of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Hashemite University, Zarqa, Jordan cMarinova Pty. Ltd., Cambridge, Tasmania, Australia. Seaweed-derived heparin-like substances such as fucoidan have been extensively studied in vitro as potential blood anticoagulants. However, there have been no human studies investigating the anticoagulant activity of fucoidan when administered orally. This pilot clinical trial was aimed to assess the safety and clinical effects of fucoidan ingestion on hemostasis as well as study its in-vitro anticoagulant activity. In a single-blinded clinical trial, a total of 20 human volunteers were allocated to both the placebo group (n = 10) who ingested 3 g of guar gum capsules and to the active treatment group (n = 10) who ingested 3 g of 75% fucoidan capsules for 12 days. Platelet indices, activated partial thromboplastin time, antithrombin-III, thrombin time, prothrombin time, and antifactor-Xa were analyzed according to standard methods. In vivo, activated partial thromboplastin time increased from 28.41 to 34.01 s (n = 10, P = 0.01), thrombin time decreased from 18.62 to 17.55 s (n = 10, P = 0.04), and antithrombin-III increased from 113.5 to 117% (n = 10, P = 0.03). The in-vitro fucoidan anticoagulant activity was found prominent. It increased activated partial thromboplastin time, thrombin time, and prothrombin time, whereas antithrombin-III decreased. In-vivo effect of fucoidan on hemostasis was not obvious probably due to low intestinal absorption . Thus, fucoidan in the form used in this study does not seem to have an oral anticoagulant activity, but it has a very strong in-vitro anticoagulant activity. PMID: 19696660 [PubMed - as supplied by publisher] .

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],Int J Food Sci Nutr. 2009;60 Suppl 2:23-34. Epub 2008 Oct 25. Dietary fiber and antioxidant capacity in Fucus vesiculosus products. Díaz-Rubio ME , Pérez-Jiménez J , Saura-Calixto F . Departamento de Metabolismo y Nutrición, IF-CSIC, Madrid, Spain. medr@if.csic.es Several nutraceutical products have been developed from Fucus vesiculosus, a brown edible seaweed, rich in dietary fiber and polyphenolic antioxidants (phlorotannins). The aim of this work was to compare the antioxidant capacity and polysaccharide composition of raw Fucus with those of some common commercial nutraceuticals. All tested products contained a high percentage of dietary fiber (45-59%), raw Fucus powder being the sample with the highest content. Also, raw Fucus powder exhibited significantly higher antioxidant capacity (determined by FRAP, ABTS and ORAC assays) than the commercial fucoidans and commercial antioxidant extracts. Polyphenols (phlorotannins) seem to be the main contributors to Fucus' antioxidant capacity in both raw powder and commercial fucoidans. PMID: 18951280 [PubMed - in process]

[object Object],Asia Pac J Clin Nutr. 2009;18(2):145-54. Could dietary seaweed reverse the metabolic syndrome? Teas J , Baldeón ME , Chiriboga DE , Davis JR , Sarriés AJ , Braverman LE . University of South Carolina Cancer Center, Department of Epidemiology and Biostatistics, 15 Greene Street 2nd Fl, Columbia, SC 29208, USA. teas@sc.edu Incidence of the metabolic syndrome is increasing worldwide, with notable exceptions of some Asian countries where seaweeds are commonly consumed. 13 men (mean age 47.4+/-9.9 yr) and 14 women (average age 45.6+/-12.2 yr) with at least one symptom of the metabolic syndrome were recruited in Quito Ecuador to a randomized double-blinded placebo-controlled trial. Subjects were assigned to either Group 1 (1 m placebo, followed by 1 m 4 g/d seaweed [Undaria pinnatifida]) or Group 2 (1 m of 4 g/d seaweed, followed by 1 m of 6 g/d of seaweed). Blood pressure, weight, waist circumference, inflammation biomarkers, and lipids were measured monthly. Repeated measures analysis of variance with Tukey's multiple comparison tests were used for statistical analysis. In Group 2, systolic blood pressure decreased 10.5 mmHg after a month of 6 g/d seaweed (95% CI: 4.1, 16.8 mmHg; p<0.05), primarily in subjects with high-normal baseline blood pressure. Waist circumference changed only for women participants, with a 2.4 cm decrease in Group 1 after treatment with placebo (95% CI: 1.0, 3.7 cm; p<0.01). In Group 2, women had a mean decrease of 2.1 cm after 4 g/d (95% CI: 0.4, 3.7 cm; p<0.05) and a further 1.8 cm decrease after 1 m 6 g/d seaweed (95 % CI: 0.1, 3.4, p<0.05). No other changes were observed. Consumption of 4 to 6 g/d seaweed, typical for most people in Japan, may be associated with low metabolic syndrome prevalence. PMID: 19713172 [PubMed - indexed for MEDLINE] Nutr Res Pract. 2008 Summer;2(2):62-7. Epub 2008 Jun 30. Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Kim MS , Kim JY , Choi WH , Lee SS . Department of Food & Nutrition, Hanyang University, Seoul 133-791, Korea. The present study was carried out to evaluate the physiological effects of seaweed supplementation on blood glucose levels, lipid profile, and antioxidant enzyme activities in subjects with type 2 diabetes mellitus. Subjects were randomized into either a control group or a seaweed supplementation group. Pills with equal parts of dry powdered sea tangle and sea mustard were provided to the seaweed supplementation group three times a day for 4 weeks. Total daily consumption of seaweed was 48 g. We found that total dietary fiber intake was 2.5 times higher in subjects receiving seaweed supplementation than in the control group. Accordingly, fasting blood glucose levels (p<0.01) and 2-hour postprandial blood glucose measurements (p<0.05) were decreased significantly in those ingesting seaweed. Furthermore, the serum concentrations of triglycerides were decreased and high-density lipoprotein cholesterol was increased significantly in seaweed supplement group (p<0.05). However, the concentrations of total cholesterol and low-density lipoprotein cholesterol were not affected by seaweed supplementation. The level of thiobarbituric acid reactive substances in erythrocytes was significantly lower with seaweed supplementation compared to controls (p<0.05). Catalase and glutathione peroxidase activities with seaweed supplementation were higher than the controls (p<0.05), but superoxide dismutase activity was not affected. We, therefore, conclude that ingestion of seaweed influences glycemic control, lowers blood lipids, and increases antioxidant enzyme activities. PMID: 20126367 [PubMed - in process]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

Casa da auga: Coruña Talasso Atlántico , Oia. Vigo

Talasoterapia: pasado y presente en A Coruña

Composición mineral agua marina

TABLA DE COMPOSICIÓN NUTRICIONAL. K (mg) Na (mg) Mg (mg) Mn (mg) Ca (mg) P (mg) Fe (mg) Se (g) Zn (mg) I (mg) Intoxicacion 2g CDR (cantidad diaria recomendada) 3500 2400 315 2.5-5 800 1500 homb 1000 muj 10:hombre 18:mujer 55:muj 70:hom 15:hom 12:muj 0.150 Dulse ( Palmaria palmata ) 800-300 200-500 560 50 10-100 Nori ( Porphyra sp ) 2030 940 370 20 330-450 235 20-30 600 100 4-6 Ulva sp. 2-10 730 87 2-3 Enteromorpha sp 6810 4880 680 0.06*10 -3 1380 235 20 590 3.93-12.01 245 Konbu ( Laminaria sp ). 2-4.2 40-100 3.8-6 Espaguetti de mar ( H.elongata ) 4330 2620 715 0.4 800-810 165 15 310 300-1100 Wakame ( Undaria pimmatifida ) 8250 4100 435 720 240 57 220 Espinacas 633 65 58 100-126 55 3-4.1 0.5 - Lechuga 240 12 25 30 0.6-1.3 0.3 0.01 Zanahoria 260-426 80-399 13-10 7-40 37-15 0.4-0.7 0.3-0.09 0.01

Irlanda. Un caso de estudio sobre algoterapia o talasoterapia con algas Kinvara, Galway. Irlanda Irish Seaweed treatment. Link

Las casas de baños de algas ,[object Object],[object Object],[object Object],[object Object], Kilcullen's Seaweed Baths . Foto Mike Guiry Celtic Seaweed Baths . Foto Mike Guiry ,[object Object],[object Object],[object Object],[object Object]

Tratamientos con algas ,[object Object],[object Object]

[object Object],[object Object],Link Baño de Algas

[object Object],[object Object]

Procesado de un peloide con algas

Preparado y masaje de un lodo de algas

Algunas marcas de cosmética que trabajan con algas ,[object Object],[object Object],[object Object],[object Object],[object Object]

Vías de aplicación. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ascophyllum nodosum Fucus sp. Maërl Laminaria sp

Tratamientos de belleza en talasoterapia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Product Proteins Carbohydrates Lipids Bakers yeast 39 38 1 Meat 43 1 34 Milk 26 38 28 Rice 8 77 2 Soy beans 37 30 20 Anabaena cylindrica 43-56 25-30 4-7 Chlamydomonas reinhardtii 48 17 21 Chlorella vulgaris 51-58 12-17 14-22 Porphyridium cruentum 28-39 40-57 9-14 Scenedesmus obliquus 50-56 10-17 12-14 Spirulina maxima 60-71 13-16 6-7 Synechococcus spec. 63 15 11

Spirulina : Dihé o Tecuitlatl ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Las más comunes son: Spirulina platensis y Spirulina maxima De similares propiedades el la Chlorella spp

En 100 g de Spirulina en polvo COMPOSICION GENERAL Proteína Carbohidratos Lípidos Minerales Humedad 55-63% 17-19% 6-8% 8-11% 4-8% COMPLEJO VITAMINACO B Y PROTEINAS B1 (Tiamina) B2 (Riboflavina) B3 (Niacina) B6 B12 Proteína 2,5 mg 3,4 mg 15 mg 462 mcg 244 mcg 60 g ACIDOS GRASOS Familia Omega 6 Gammalinolenico (GLA) Linoleico esencial Dihomogamma linolenico Familia Omega 3 Alfalinolenico Familia Monoenoica Palmitoleico Oleico Erúcico 650-990 mg 1,09 g 52 mg . 1,44 mg . 196 mg 217 mg 2,38 mg MINERALES Y OLIGOELEMENTOS Calcio Magnesio Hierro Fósforo Potasio Manganeso Cinc Boro Cobre Molibdeno Selenium 277 mg 334 mg 56 mg 990 mg 1,95 g 3,8 mg 2,3 g 990 mcg 495 mcg 247,5 mcg 257,4 mcg OTROS ACIDOS GRASOS Acido Palmitico Acido Miristico Acido Esteárico Acido Araquidico Acido Behénico Acido Lignocérico 1,98 g 107 mg 6,7 mg 4,8 mg 4,8 mg 2,4 mg PIGMENTOS/CAROTENOIDES Y FITONUTIENTES Beta-caroteno 9- cis Beta-caroteno 13- cis Beta-caroteno 15- cis Beta-caroteno todo trans Zeaxantina Clorofila Total de carotenoides* 429 mg Ficocianina Superóxido de dismutasa** 52,8mg 16,8mg 4 mg 257mg 31mg 990 mg 429 mg 11 g 85,800 unidades * Incluye alfa-caroteno, beta criptoxantina, y otros. ** Reportado como actividad purificadora de superóxido

4 Propiedates TerapéUticas De Las Algas

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (8)

Similar a 4 Propiedates TerapéUticas De Las Algas

Similar a 4 Propiedates TerapéUticas De Las Algas (20)

Más de Consellería de Educación, Universidade e Formación Profesional. Xunta de Galicia

Más de Consellería de Educación, Universidade e Formación Profesional. Xunta de Galicia (20)

4 Propiedates TerapéUticas De Las Algas

Notas del editor